Loading companies…

Careteq Ltd ASX:CTQ

0 opened or increased0 held0 reduced or exitedlatest position by manager, past 12 months90 days: 0 increased, 0 reduced. 1 managers in total.

Position history by manager 1 managersSelect a point to see the comment

Opened or increasedHeldReduced or exited Start or end of the position not reported

20252026

7 Jan 2024 to today

Commentary Showing 2 of 3

DateManagerActionSummary

31 Mar 2024DMX Asset ManagementHeldDMX Asset Management continues to hold Careteq Ltd following a mixed month that included both a negative ATO position paper — challenging approximately $1.3 million in R&D tax offsets — and the positive appointment of an experienced ASX executive as CEO. DMX Asset Management notes that Careteq disputes the ATO's position and has been invited to make further technical and factual submissions. The company reaffirmed a positive outlook, targeting profitability and cash flow positivity heading into FY25. With a current enterprise value of approximately $1 million, the fund sees potential for accelerated growth under new leadership.

Monthly Report

The source document link is a Pro feature

31 Jan 2024DMX Asset ManagementHeldThe fund manager continues to hold Careteq (CTQ), noting the company's quarterly report was in line with expectations with operational targets reaffirmed. The manager highlights the core Embedded Health Solutions business continues to deliver free cash flow and is on track to achieve its $1.5 million EBITDA FY24 target, while the Sofihub monitoring business continues to grow strongly. The manager expects improvement in overall group cash flow, with management confident that foundations for profitable growth are in place targeting 15,000 devices by end of FY25.

Monthly Report, price recorded $0.03

The source document link is a Pro feature

1 more comments on CTQPro shows every comment, with a link to each source document.

Upgrade to Pro

First mention by manager

Price recorded at each manager's first comment

Price at first mentionThe share price recorded when each of 1 managers first commented on CTQ.

View Pro

About Careteq Ltd

Healthcare, Health Care Technology

Careteq (ASX:CTQ), an aged care technology company, has been followed closely by DMX Asset Management through an eventful period. In March 2024, DMX noted Careteq received an ATO position paper indicating the tax office believed the company had not provided adequate evidence for certain claims, creating a negative development. Earlier, DMX described Careteq as a recent portfolio addition focused on technology solutions for aged care, with its quarterly report in line with expectations and operational targets reaffirmed. Careteq operates in the Healthcare sector within the Health Care Technology industry, and Thesis Tracker has captured 3 comments from 1 fund manager, DMX Asset Management. Founded in 2016 by Elizabeth Crooks, Ian Aitken and Steve Stapelberg and headquartered in Melbourne, Careteq provides residential medication management reviews, home medicine reviews and embedded pharmacist services in aged care, along with technology to improve medication safety and care coordination for residents and providers.

Market cap: $12m
Price to earnings: Loss-making
Return on equity: -16.8%
Dividend yield: 0.0%
Price to book: 1.78x
Net margin: -5.8%
52-week range: $0.01 to $0.02

Company figures as of 15 Oct 2026. For information only.

Questions

Who is investing in Careteq Ltd (ASX:CTQ)?

Fund managers including DMX Asset Management have invested in Careteq Ltd (ASX:CTQ).

What opportunities or catalysts do fund managers highlight for Careteq Ltd?

DMX highlights Careteq's position in aged care medication management, reaffirmed operational targets and its embedded pharmacist business, which benefits from government reforms to aged care.

What are the key risks to the Careteq Ltd investment thesis, according to fund managers?

DMX notes an ATO position paper challenging the company's evidence for certain claims, which could result in adverse tax outcomes.

What does Careteq Ltd (ASX:CTQ) do?

Careteq Ltd. is an Australian healthcare company headquartered in Melbourne. Founded in 2016 by Elizabeth Crooks, Ian Aitken, and Steve Stapelberg, the firm specializes in residential medication management reviews and home medicines review services. Careteq operates through its core brands, HMR Referrals and Embedded Health Solutions. The company focuses on clinical review services designed to optimize medication safety and health outcomes within residential and home-based care environments.

General information only. Thesis Tracker reports what named fund managers have published about ASX companies. It does not take into account your objectives, financial situation or needs, and is not financial product advice or a recommendation to buy, sell or hold any security.

11,356 comments from 164 managers on 761 companies, snapshot 15 Oct 2026.

Disclaimer Terms of Use Privacy Complaints Contact

Loading…